01 1Chongqing DaXin Pharmaceutical
01 1MYCOPHENOLATE MOFETIL
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-08-23
Pay. Date : 2023-07-11
DMF Number : 36449
Submission : 2021-12-01
Status : Active
Type : II
20
Chongqing Daxin Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is MYCOPHENOLATE MOFETIL, with a corresponding US DMF Number 36449.
Remarkably, this DMF maintains an Active status since its submission on December 01, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 23, 2023, and payment made on July 11, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
